机构:[1]Department of Hepato-Pancreato-Biliary Surgery, First People's Hospital of Kunming, No. 504 Qinnian Road, Kunming, 650032 Yunnan, China.[2]Department of Hepato-Pancreato-Biliary Surgery, The Calmette Affiliated Hospital of Kunming Medical University, Kunming, 650032 Yunnan, China.
This study was supported by the Yunnan Provincial Department
of Science and Technology (202205AC160089), Yunnan
Provincial Health Commission Medical Discipline Leader
Training Program (D-2018032), (Kunming) Academician
and Expert Workstation (YSZJGZZ-2020025), Yunnan Provincial
Academician and Expert Workstation-Research Talent
and Platform Program (202205AF150064), National Natural
Science Foundation of China, Regional Science Fund Project
(82060436) and Key school level projects of the 14th five year
plan of Kunming Medical University.
第一作者机构:[1]Department of Hepato-Pancreato-Biliary Surgery, First People's Hospital of Kunming, No. 504 Qinnian Road, Kunming, 650032 Yunnan, China.[2]Department of Hepato-Pancreato-Biliary Surgery, The Calmette Affiliated Hospital of Kunming Medical University, Kunming, 650032 Yunnan, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Hepato-Pancreato-Biliary Surgery, First People's Hospital of Kunming, No. 504 Qinnian Road, Kunming, 650032 Yunnan, China.[2]Department of Hepato-Pancreato-Biliary Surgery, The Calmette Affiliated Hospital of Kunming Medical University, Kunming, 650032 Yunnan, China.
推荐引用方式(GB/T 7714):
Zongqiang Hu,Jiapeng Chen,Yingpeng Zhao,et al.Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3[J].JOURNAL OF IMMUNOLOGY RESEARCH.2022,2022:doi:10.1155/2022/1032106.
APA:
Zongqiang Hu,Jiapeng Chen,Yingpeng Zhao,Chuntao Yan,Yiting Wang...&Li Li.(2022).Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3.JOURNAL OF IMMUNOLOGY RESEARCH,2022,
MLA:
Zongqiang Hu,et al."Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3".JOURNAL OF IMMUNOLOGY RESEARCH 2022.(2022)